BioNexus Gene Lab Corp. The company is headquartered in Kuala Lumpur, Malaysia.
| Revenue (TTM) | $5.31M |
| Gross Profit (TTM) | 740,930 |
| EBITDA | $-2.96M |
| Operating Margin | -2466.00% |
| Return on Equity | -36.60% |
| Return on Assets | -20.80% |
| Revenue/Share (TTM) | $2.64 |
| Book Value | $3.35 |
| Price-to-Book | 0.60 |
| Price-to-Sales (TTM) | 0.92 |
| EV/Revenue | 0.211 |
| EV/EBITDA | 629.53 |
| Quarterly Earnings Growth (YoY) | -95.00% |
| Quarterly Revenue Growth (YoY) | -98.90% |
| Shares Outstanding | $2.42M |
| Float | $1.75M |
| % Insiders | 35.59% |
| % Institutions | 0.01% |
Volatility is currently contracting